semaglutide new york times Wegovy Approved By FDA to Reduce Heart Attack Risk How 'miracle' weight-loss drugs made

increased slightly between 2021 and 2024, but their uptake remained limited, with *ONLY 3%* of eligible patients having ever received a prescription during that period." "Low adoption and disparities in use likely reflect both system-level access barriers and patient-level demand, including narrow eligibility, limited insurance coverage, and financial considerations that may lead some individuals to forgo treatment after prescription." *NOTE: "did not include prescriptions from online-only pharmacies" and "products for diabetes were excluded" #obesity #medication #treatment #GLP1 #semaglutide #tirzepatide Sean C

Consultation : Engage with a licensed provider to determine if oral semaglutide suits you

Impact in Type 2 Diabetes In individuals with type 2 diabetes, Retatrutide also improved glycemic control, though weight loss outcomes were slightly less dramatic compared to non-diabetic participants

For most people, this wont be a problem, and symptoms are manageable